Titan Biotech Ltd (NSE: TITANBIO), ISIN INE150C01029 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
TITANBIO last traded at ₹428.00 (+2.11%), with a 52-week range of ₹82.31 to ₹555.65 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 55.78%, FIIs 0.00%, DIIs 0.03%, mutual funds 0.00%.
EquiSense Score (ECS): 78/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.